AISLING CAPITAL LLC Information

888 SEVENTH AVENUE, 30TH FLOOR, NEW YORK, New York, 10106, (212) 651-6372

Report Date: 03/31/2015

Position Statistics

Total Positions 19
New Positions 0
Increased Positions 2
Decreased Positions 3
Positions with Activity 5
Sold Out Positions 1
Total Mkt Value (in $ millions) 753

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates 6.22%
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial
Healthcare 36.03%
Services
Technology
Transportation
Utilities

19 Positions as of 03/31/2015

Company Class Value of Shares ($1,000s) ▼ Change in Value ($1,000s) Change (%) Shares Held
ESPERION THERAPEUTICS INC NEW COM 169,031 New 2,054,594
CEMPRA INC COM 111,305 New 3,293,060
ZELTIQ AESTHETICS INC COM 76,010 New 2,597,742
LOXO ONCOLOGY INC COM 62,697 New 3,452,493
CHIMERIX INC COM 46,851 -22,900 (32.83) 1,022,943
T2 BIOSYSTEMS INC COM 39,616 New 2,523,300
VERSARTIS INC COM 34,285 4,286 14.29 2,279,568
ADMA BIOLOGICS INC COM 34,278 New 3,608,171
CATALENT INC COM 32,892 -19,452 (37.16) 1,106,729
SORRENTO THERAPEUTICS INC COM NEW 30,350 New 1,763,500
AGILE THERAPEUTICS INC COM 25,720 6,999 37.39 2,983,797
TRANSENTERIX INC COM NEW 24,174 New 8,335,819
DERMIRA INC COM 19,550 New 1,102,046
PARATEK PHARMACEUTICALS INC COM 17,709 New 682,680
PERNIX THERAPEUTICS HLDGS INC COM 11,638 New 2,010,000
INTERSECT ENT INC COM 9,937 New 350,000
LOMBARD MED INC COM 3,670 New 886,363
ROKA BIOSCIENCE INC COM 2,974 New 1,122,417
MEI PHARMA INC COM NEW -1,720 Sold Out 0